Supernus Pharmaceuticals (SUPN) Gross Margin Growth (5y) (2018 - 2025)

Supernus Pharmaceuticals (SUPN) Gross Margin Growth (5y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Supernus Pharmaceuticals 2.63 Bn 2.24 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 204.00
Sep 30, 2025 391.00
Jun 30, 2025 -355.00
Mar 31, 2025 -615.00
Dec 31, 2024 -1,089.00
Sep 30, 2024 -529.00
Jun 30, 2024 -678.00
Mar 31, 2024 -704.00
Dec 31, 2023 -833.00
Sep 30, 2023 -865.00
Jun 30, 2023 -1,186.00
Mar 31, 2023 -1,163.00
Dec 31, 2022 -902.00
Sep 30, 2022 -930.00
Jun 30, 2022 -694.00
Mar 31, 2022 -664.00
Dec 31, 2021 -464.00
Sep 30, 2021 -615.00
Jun 30, 2021 -1,238.00
Mar 31, 2021 -682.00